Myriad Publishes myRisk Hereditary Cancer Study In Cancer
September 03, 2014 at 16:06 PM EDT
Myriad Genetics, Inc. (Nasdaq: MYGN), today announced that the Myriad myRisk™ Hereditary Cancer test significantly improved the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.